Success Story: EB-2 NIW Approval in Under 6 Months for a Postdoctoral Research Fellow from Pakistan
Client’s Testimonial:
"Working with Chen Immigration Law Associates was an outstanding experience from start to finish. Their team was highly professional, detail-oriented, and strategic in presenting my research background and long-term contributions to cardiovascular medicine. I truly appreciate their guidance and support throughout the process, which resulted in my EB-2 NIW approval in under 6 months without an RFE.”
On April 30th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Cardiovascular Disease (Approval Notice).
General Field: Cardiovascular Disease
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Pakistan
State of Residence at the Time of Filing: Mississippi
Approval Notice Date: April 30th, 2026
Processing Time: 5 months, 13 days
Case Summary:
"Considering the merit of [Client]’s work in conjunction with his publication by multiple prestigious outlets, [Client] has established himself as a valued leader and irreplaceable asset in cardiovascular disease."
The statement above is taken from one of two recommendation letters submitted as part of the I-140 NIW (National Interest Waiver) petition for a postdoctoral research fellow who holds an M.B.B.S. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition on behalf of this exceptional researcher. The petition was approved in under 6 months without RFE.
Because the client is an expert in cardiovascular disease, his proposed endeavor is to continue researching the burden, outcomes, and therapeutic strategies related to CVDs and their complications in order to inform clinical decision-making, guide public health policy, and reduce disparities in cardiovascular care. We demonstrated that this work addresses critical national health priorities, as heart disease remains the leading cause of death in the United States.
- 26 peer-reviewed journal articles (5 of them first-authored), 14 conference abstracts (2 of them first-authored), and 7 consortium papers
- 819 citations
- At least 30 peer reviews
This research synthesizes large-scale clinical and population data to evaluate the prevalence, outcomes, and treatment pathways of CVDs, generating actionable insights that strengthen medical decision-making, shape national health strategies, and lessen both the human and economic burden of heart disease across the United States. The client's work is particularly notable for its focus on underserved populations.
It has been an honor to support this exceptional cardiovascular disease researcher throughout this journey, and we extend our sincere best wishes for continued success in advancing evidence-based cardiovascular care and improving health outcomes for patients across the United States and beyond.

